Multi-omics: The future of biomarker discovery.

Disease biology is inherently complex, and single-omics approaches often fall short in capturing the full molecular picture required for meaningful biomarker discovery. Multi-omics integration is driving a new era of biomarker research, offering a more comprehensive, systems-level understanding of disease. By strategically combining multiple omics types, researchers can uncover novel and robust biomarkers while overcoming the limitations of isolated data layers.

In this webinar, we explore how various omics technologies form the foundation for biomarker discovery and why multi-omics offers a more reliable path to high-quality biomarkers. Using real-world examples, we cover the use of multi-omics for discovery and explore the pathway for translating these research findings into biomarkers with potential clinical utility.

Key learnings include:

• Understanding the multi-omics advantage for discovery of high-quality biomarkers in precision medicine research
• Real-word examples from the Revvity Omics Services team:
  • Insights into the development and evaluation of a 12-analyte metabolomics panel for detecting multiple Inborn Errors of Metabolism (IEM)
  • Discovery and validation of a biomarker panel for Type-1 Diabetes that supports early detection and longitudinal monitoring
  • Using multi-omics-based biomarkers for diagnosis of Duchenne Muscular Dystrophy (DMD)

Disclaimer: This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offers is dependent upon laboratory location. This content is provided for informational purposes only, not as medical advice. It is not intended to substitute the consultation, diagnosis, and/or treatment provided by a qualified licensed physician or other medical professional.